Oncology disease model cell lines
April 2011

Sigma Life Science
Sigma Life Science, the biological products and services research business of Sigma-Aldrich, announces the addition of new genetically modified cancer cells to the company's range of high-quality cell lines. Sigma's CompoZr Oncology Disease Model cell lines are designed to enable basic research and high- content, high-throughput screening of compounds and biologics. Sigma will start its offering with cell lines that model colorectal and lung cancer. Later this year, this portfolio will expand with the introduction of a panel of genetically modified cell lines that model breast cancer.    
Sigma Life Science
(800) 521-8956

1000 N West Street, Suite 1200,
Wilmington, Delaware, 19801
Ph: 888-781-0328 |  Fax: 705-528-0270
© Copyright 2020 Old River Publications LLC. All righs reserved.  |  Web site managed and designed by OffWhite.